Announcements Trials

Browse Landscape

Phase

Status

Completed 25 Terminated 12 Active not recruiting 10 Recruiting 8 Withdrawn 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, B-Cell 1

Interventions

Specimen Handling 17 Biopsy 12 Magnetic Resonance Spectroscopy 10 Cyclophosphamide 9 venetoclax 5 Etoposide 4 Azacitidine 4 fludarabine phosphate 3 fludarabine 3 durvalumab 3 X-Rays 3 Tacrolimus 3 Paclitaxel 3 Interleukin-2 3 Gemcitabine 3 Cisplatin 3 Carboplatin 3 zanubrutinib 2 prednylidene 2 deltacortene 2 aldesleukin 2 Vincristine 2 Taxes 2 Stem Cell Transplantation 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Protein Subunit Vaccines 2 Prednisone 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Suspended × obinutuzumab × Clear all

NCT06824701 2026-04-06

TARZAN

University of Utah

Phase 1 Suspended

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡